{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2022,3,30]],"date-time":"2022-03-30T06:59:31Z","timestamp":1648623571359},"reference-count":3,"publisher":"Oxford University Press (OUP)","issue":"4","license":[{"start":{"date-parts":[[2014,3,20]],"date-time":"2014-03-20T00:00:00Z","timestamp":1395273600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/journals\/pages\/open_access\/funder_policies\/chorus\/standard_publication_model"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2014,4,1]]},"abstract":"<jats:p>This letter describes the first demonstration of clinical response to the anti-EGFR inhibitor gefitinib in a case of urothelial carcinoma of the renal pelvis harboring a rare EGFR double mutation. New mutations and unexpected clinical responses should be always explored through wide-spectrum mutational analyses.<\/jats:p>","DOI":"10.1634\/theoncologist.2013-0346","type":"journal-article","created":{"date-parts":[[2014,3,21]],"date-time":"2014-03-21T00:47:11Z","timestamp":1395362831000},"page":"430-430","source":"Crossref","is-referenced-by-count":2,"title":["Learning From Errors: Response to Gefitinib in Kidney Urothelial Carcinoma With <i>EGFR<\/i> Mutations"],"prefix":"10.1093","volume":"19","author":[{"given":"Michelangelo","family":"Fiorentino","sequence":"first","affiliation":[{"name":"Pathology Service, Addarii Institute of Oncology, Bologna, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Francesca","family":"Giunchi","sequence":"additional","affiliation":[{"name":"Pathology Service, Addarii Institute of Oncology, Bologna, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Annalisa","family":"Altimari","sequence":"additional","affiliation":[{"name":"Pathology Service, Addarii Institute of Oncology, Bologna, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"PierGiorgio","family":"Di Tullio","sequence":"additional","affiliation":[{"name":"Medical Oncology Unit, S. Orsola-Malpighi Hospital, Bologna, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Elisa","family":"Gruppioni","sequence":"additional","affiliation":[{"name":"Pathology Service, Addarii Institute of Oncology, Bologna, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Giuseppe","family":"Martorana","sequence":"additional","affiliation":[{"name":"Department of Urology, S. Orsola-Malpighi Hospital, Bolgna, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Carmine","family":"Pinto","sequence":"additional","affiliation":[{"name":"Medical Oncology Unit, S. Orsola-Malpighi Hospital, Bologna, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"286","published-online":{"date-parts":[[2014,3,20]]},"reference":[{"key":"2021122308525134000_B1","doi-asserted-by":"crossref","first-page":"4671","DOI":"10.1158\/1078-0432.CCR-06-0407","article-title":"Mutations within the kinase domain and truncations of the epidermal growth factor receptor are rare events in bladder cancer: Implications for therapy","volume":"12","author":"Blehm","year":"2006","journal-title":"Clin Cancer Res"},{"key":"2021122308525134000_B2","doi-asserted-by":"crossref","first-page":"1590","DOI":"10.1016\/j.humpath.2011.11.016","article-title":"High epidermal growth factor receptor immunohistochemical expression in urothelial carcinoma of the bladder is not associated with EGFR mutations in exons 19 and 21: A study using formalin-fixed, paraffin-embedded archival tissues","volume":"43","author":"Chaux","year":"2012","journal-title":"Hum Pathol"},{"key":"2021122308525134000_B3","doi-asserted-by":"crossref","first-page":"2480","DOI":"10.1002\/ijc.23868","article-title":"EGFR genetic heterogeneity of nonsmall cell lung cancers contributing to acquired gefitinib resistance","volume":"123","author":"Jiang","year":"2008","journal-title":"Int J Cancer"}],"container-title":["The Oncologist"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/pericles-gcp.literatumonline.com\/doi\/pdf\/10.1634\/theoncologist.2013-0346","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/pericles-gcp.literatumonline.com\/doi\/full-xml\/10.1634\/theoncologist.2013-0346","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/academic.oup.com\/oncolo\/article-pdf\/19\/4\/430\/41862361\/oncolo_19_4_430.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/oncolo\/article-pdf\/19\/4\/430\/41862361\/oncolo_19_4_430.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,12,23]],"date-time":"2021-12-23T08:53:43Z","timestamp":1640249623000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/oncolo\/article\/19\/4\/430\/6399577"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,3,20]]},"references-count":3,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2014,3,20]]},"published-print":{"date-parts":[[2014,4,1]]}},"URL":"https:\/\/doi.org\/10.1634\/theoncologist.2013-0346","relation":{},"ISSN":["1083-7159","1549-490X"],"issn-type":[{"value":"1083-7159","type":"print"},{"value":"1549-490X","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2014,4,1]]},"published":{"date-parts":[[2014,3,20]]}}}